kuvura kanseri nini yo kuvura kanseri y'ibihaha

Kanseri nini y'ibihaha (LCLC) ni ubwoko bukabije bwa kanseri y'ibihaha itari ntoya (NSCLC). Uburyo bwo kuvura akenshi burimo guhuza kubaga, chimiotherapie, kuvura imirasire, kuvura intego, hamwe na immunotherapie, bijyanye nicyiciro cyumurwayi ku giti cye, ubuzima rusange, nibiranga ibibyimba byihariye. Iterambere rya vuba mu mwirondoro wa molekuline hamwe nubuvuzi bwihariye burimo kunoza ibisubizo kubasuzumwe na LCLC. Kumva Kanseri Nini Yibihaha Kanseri Nini Kanseri yibihaha?Kuvura kanseri y'ibihaha binini (LCLC) ni ubwoko bwa kanseri y'ibihaha itari nto. Irabona izina ryayo kuva selile nini, idasanzwe-igaragara igaragara munsi ya microscope. LCLC ikunda gukura no gukwirakwira vuba, bigatuma kwisuzumisha hakiri kare no kuvurwa ari ngombwa. Mugihe bidakunze kugaragara kuruta ubundi bwoko bwa NSCLC, gusobanukirwa ibiranga ni ngombwa mugucunga neza.Ibintu bishobora guteza ingaruka no kwirindaBisa na kanseri y'ibihaha, kunywa itabi nicyo kintu cyambere gitera LCLC. Ibindi bishobora guteza ingaruka harimo guhura numwotsi w itabi, radon, asibesitosi, nibintu bimwe na bimwe byinganda. Kureka itabi, kwirinda guhura na kanseri izwi, no gukomeza ubuzima buzira umuze ni ingamba nziza zo kwirinda. Kwipimisha buri gihe no gusuzuma kanseri y'ibihaha kubantu bafite ibyago byinshi birashobora no gufasha gutahura hakiri kare kandi birashobora gutera imbere kuvura kanseri y'ibihaha binini ibisubizo. Uburyo bwo kubaga bushobora gukuramo gukuramo igice cyibihaha (wedge resection cyangwa segmentectomy), lobe yose (lobectomy), cyangwa nibihaha byose (pneumonectomy). Guhitamo kubagwa biterwa nubunini n’aho ikibyimba giherereye, hamwe n’imikorere y’ibihaha umurwayi muri rusange. Amatsinda yo kubaga ikigo cya Shandong Baofa yubushakashatsi afite uburambe muri ubu buryo.ChemotherapyChemotherapie ni uburyo bwa sisitemu ikoresha imiti yica kanseri yica umubiri wose. Bikunze gukoreshwa muburyo bwo kubaga cyangwa kuvura imirasire, cyangwa nkubuvuzi bwibanze bwa LCLC igezweho. Uburyo bwa chimiotherapie busanzwe bwa LCLC burimo imiti ishingiye kuri platine (nka cisplatine cyangwa karboplatine) ihujwe nubundi buryo bwa chimiotherapie. Ingaruka mbi za chimiotherapie zirashobora kubamo isesemi, umunaniro, guta umusatsi, hamwe no kongera ibyago byo kwandura. Irashobora gukoreshwa mu kuvura LCLC muburyo butandukanye: nkubuvuzi bwibanze kubarwayi bataba abakandida kubagwa, nkumuti wongeyeho nyuma yo kubagwa kugirango wice selile zose zisigaye, cyangwa kugabanya ibimenyetso nkububabare cyangwa guhumeka neza muburwayi bwateye imbere. Ubwoko bwimiti ivura imirasire ikoreshwa muri LCLC harimo imiti ivura imirasire yo hanze (EBRT) hamwe nubuvuzi bwa stereotactique yumubiri (SBRT) .Targeted TherapyTargeted therapy imiti yibasira cyane molekile cyangwa inzira zigira uruhare mu mikurire ya kanseri no kubaho. Ubu buvuzi bufite akamaro kanini kubarwayi bafite ihindagurika ryimiterere yabantu mubyimba byabo. Intego rusange muri LCLC zirimo EGFR, ALK, ROS1, na BRAF. Mbere yo gutangira kuvura, abarwayi bakunze kwipimisha molekuline kugirango bamenye niba ibibyimba byabo bifite kimwe muri ibyo bihinduka. Niba ukeneye ubufasha runaka, Ikigo cyubushakashatsi bwa Kanseri ya Baofa kirashobora gutanga serivisi zo gupima ingirabuzima fatizo.ImmunotherapyImmunotherapy ikoresha imbaraga z'umubiri w’umubiri urwanya kanseri. Immune igenzura, nka pembrolizumab, nivolumab, na atezolizumab, ni ubwoko bwa immunotherapie ibuza poroteyine zibuza umubiri kwirinda indwara ya kanseri. Immunotherapy yerekanye ibisubizo bitanga umusaruro mukuvura LCLC, cyane cyane kubarwayi bafite ibibyimba byerekana urugero rwa PD-L1. Irashobora gukoreshwa nkumurongo wambere wokuvura LCLC yo murwego rwohejuru cyangwa nyuma ya chimiotherapie yananiwe.Iterambere muburyo bunini bwo kuvura kanseri yibihaha yo mu ngirabuzimafatizoMilecular ProfilingMolecular profiling ikubiyemo gusesengura ingirangingo yibibyimba byumurwayi kugirango hamenyekane ihinduka ryimiterere yihariye ya genetike cyangwa izindi mpinduka zishobora gutera kanseri gukura. Aya makuru arashobora gufasha abaganga guhitamo uburyo bukwiye bwo kuvura cyangwa gukingira indwara kuri buri murwayi. Urukurikirane rw'ibisekuru bizakurikiraho (NGS) ni tekinike isanzwe ikoreshwa mu kwerekana imiterere ya molekile, ituma habaho icyarimwe kumenya ihinduka ry’imiterere ihindagurika. Ubuvuzi bwihariye. kuvura kanseri y'ibihaha binini kumurwayi kugiti cye ashingiye kumiterere yibibyimba byabo, ubuzima rusange, nibyo akunda. Ubu buryo bugamije kwerekana uburyo bwiza bwo kuvura mugihe hagabanijwe ingaruka mbi. Ubuvuzi bwihariye buragenda burushaho kuba ingenzi mu micungire ya LCLC, kuko ituma abaganga bahitamo ingamba zikwiye zo kuvura kuri buri murwayi. Ibigeragezo by’amavuriroIbizamini bya kliniki ni ubushakashatsi bwakozwe busuzuma uburyo bushya bwo kuvura cyangwa guhuza imiti ivura LCLC. Kwitabira ikizamini cyamavuriro birashobora guha abarwayi uburyo bwo kuvura butaraboneka henshi. Igeragezwa rya Clinical nigice cyingenzi mugutezimbere ubuvuzi bwa kanseri, kandi abarwayi bagomba kuganira nabaganga babo niba kwitabira kwipimisha kwa muganga ari amahitamo meza kuri bo.Ibipimo byo gutangaza no kurokokaIbipimo bya LCLC biratandukana bitewe nibintu byinshi, birimo icyiciro cya kanseri mugupima, ubuzima bwumurwayi muri rusange, nigisubizo cyo kwivuza. Icyiciro cya mbere LCLC ivurwa no kubagwa ifite prognoza nziza kuruta LCLC yo murwego rwohejuru yakwirakwiriye kurubuga rwa kure. Iterambere mu buvuzi, nk'ubuvuzi bugamije kuvura no gukingira indwara, ryazamuye ubuzima bw'abarwayi bafite LCLC mu myaka yashize. Igipimo cyimyaka 5 yo Kurokoka Kanseri Yibihaha Atari Ntoya (NSCLC) na Stage1 Icyiciro cya 5 Icyiciro cyo Kurokoka Imyaka 5 Yegereye 63% Uturere 36% Intera 8% Ibyiciro byose byabareba 26% * Icyitonderwa: Izi mibare yo kubaho zishingiye kumibare yatanzwe na gahunda yigihugu ishinzwe kugenzura kanseri, Epidemiologiya, hamwe n ibisubizo birangiye (SEER). guhangana n'ingaruka z'umubiri n'amarangamutima y'indwara. Amatsinda atera inkunga, ubujyanama, hamwe nubuvuzi bwa palliative arashobora gutanga ubufasha bwingirakamaro. Kugumana ubuzima buzira umuze, harimo indyo yuzuye hamwe na siporo isanzwe, birashobora kandi kuzamura imibereho. Kuganira ku bibazo n'ibibazo hamwe nitsinda ryanyu ryita ku buzima ni ngombwa mu gucunga neza LCLC.Gushakisha Inkunga n’umutungoImiryango myinshi itanga inkunga n’ibikoresho kubantu basuzumwe na LCLC nimiryango yabo. Ibikoresho birimo ibikoresho byuburezi, amatsinda atera inkunga, gahunda zifasha amafaranga, nimbaraga zo kunganira. Guhuza nibi bikoresho birashobora gutanga ubufasha nubuyobozi mugihe cyurugendo rwa kanseri.Reba: Sosiyete y'Abanyamerika ya Oncology Clinical (ASCO): Kanseri y'ibihaha - Akagari kitari gito: Imibare.